Products

Anti-TNFRSF17 Therapeutic Antibody (J22.9-xi) (TAB-0137CL)

Anti-BCMA antibody can bind BCMA, which belongs to the tumour necrosis factor receptor superfamily, thereby preventing the interaction between the BCMA and its ligands, such as BAFF and APRIL. The specific antibody can be used in the treatment of plasma cell-mediated diseases like multiple myeloma and autoimmune diseases.      

Specifications
Immunogen
Extracellular domain of human BCMA (C-terminally fused to Glutathione S-transferase (GST))
Host
Mouse
Type
Chimeric
Specificity
Human
Clone
J22.9-xi
Related Disease
Plasma cell-mediated diseases such as multiple myeloma and autoimmune diseases
Target
Alternative Names
TNFRSF17; tumor necrosis factor receptor superfamily, member 17; BCM; BCMA; CD269; TNFRSF13A; tumor necrosis factor receptor superfamily member 17; B-cell maturation factor
Entrez Gene ID
608
UniProt ID
Q02223

For lab research use only, not for diagnostic, therapeutic or any in vivo human use.

Our customer service representatives are available 24 hours a day, from Monday to Sunday. Contact Us
Send Inquiry Now!
Name:
* Phone:
* E-mail Address:
* Service & Products Interested:
Project Description:
* Verification Code:
Please input "biolabs"(case insensitive) as verification code.
Contact Us to Order
Tel: 1-631-871-5806
Fax: 1-631-207-8356
Email:

45-1 Ramsey Road, Shirley, NY 11967, USA     Tel: 1-631-871-5806    Fax: 1-631-207-8356    Email:
Terms of Service-Privacy Policy     © 2007 - 2017 Creative-Biolabs All Rights Reserved